Author

Sara Shahabipour

PhD candidate, University of Mohaghegh Ardabili - Cited by 189 - Physical Chemistry - Quantum Chemistry - Computational Chemistry - Computational Drug Design

Biography

Sara Shahabipour completed her PhD in Department of Chemistry University of Mohaghegh Arabili in Physical Chemistry and currently working in Medicinal & Natural Product Chemistry Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran She has skill and expertised in UV-Visible sprectoscopy , Gas Liquid Chromatography , Molecular Modelling , Virtual Screening .
Title
Cited by
Year
Essential oil composition and cytotoxic activity of Ducrosia anethifolia and Ducrosia flabellifolia from Iran
S Shahabipour, O Firuzi, M Asadollahi, E Faghihmirzaei, K JavidniaJournal of Essential Oil Research 25 (2), 160-163, 2013201
29
2013
Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis
N Razzaghi-Asl, A Ebadi, S Shahabipour, D GholaminJournal of Biomolecular Structure and Dynamics 39 (17), 6633-6648, 2021202
25
2021
Validation of an Analytical Method for Determination of Benzo [a] pyrene Bread using QuEChERS Method by GC-MS
S Eslamizad, H Yazdanpanah, K Javidnia, R Sadeghi, M Bayat, ...Iranian journal of pharmaceutical research: IJPR 15 (2), 465, 2016201
17
2016
Ab-Initio and conformational analysis of a potent VEGFR-2 inhibitor: A case study on motesanib
A Ebadi, N Razzaghi-Asl, S Shahabipour, R MiriIranian Journal of Pharmaceutical Research: IJPR 13 (2), 405, 2014201
17
2014
Response surface methodology in docking study of small molecule BACE-1 inhibitors
N Razzaghi-Asl, A Ebadi, N Edraki, A Mehdipour, S Shahabipour, R MiriJournal of molecular modeling 18, 4567-4576, 2012201
17
2012
Molecular docking and quantum mechanical studies on biflavonoid structures as BACE-1 inhibitors
N Razzaghi-Asl, S Sepehri, A Ebadi, R Miri, S ShahabipourStructural Chemistry 26, 607-621, 202
15
2015
Ab initio modeling of a potent isophthalamide-based BACE-1 inhibitor: amino acid decomposition analysis
N Razzaghi-Asl, A Ebadi, N Edraki, S Shahabipour, R MiriMedicinal Chemistry Research 22, 3259-3269, 2013201
15
2013
Effect of biomolecular conformation on docking simulation: a case study on a potent HIV-1 protease inhibitor
N Razzaghi-Asl, S Sepehri, A Ebadi, R Miri, S ShahabipourIranian journal of pharmaceutical research: IJPR (3), 785, 2015201
14
2015
Fragment-based binding efficiency indices in bioactive molecular design: a computational approach to BACE-1 inhibitors
N Razzaghi-Asl, A Ebadi, N Edraki, S Shahabipour, R MiriIranian Journal of Pharmaceutical Research: IJPR 12 (3), 423, 2013201
11
2013
Essential oil composition and cytotoxic activity of Libanotis transcaucasica schischk from Iran
S Shahabipour, O Firuzi, M Asadollahi, M Miri, K JavidniaNatural Products Chemistry & Research 1 (108), 1-2, 2013201
9
2013
Chemical constituents and cytotoxic activity of the essential oil of Libanotis transcaucasica Schischk from Iran
S Shahabipour, K Javidnia, O Firuzi, R MiriResearch in Pharmaceutical Sciences (5), 45, 2012201
7
2012
Evaluation of the valuable oxygenated components in iranian rose water
M Mahboubifar, S Shahabipour, K JavidniaIntern Int J Chemtech Res , 4782-4788, 2014201
6
2014
Quantum chemical analysis of potential anti-Parkinson agents
N Razzaghi-Asl, S Shahabipour, A Ebadi, A BagheriJournal of Chemical Sciences 127, 1211-1220, 2015201
4
2015
A new insight into computational molecular design: A case study on BACE-1 inhibitors
N Razzaghi-Asl, B Hemmateenejad, A Ebadi, S Shahabipour, R MiriJournal of Computational Methods in Sciences and Engineering 14 (4-5), 315-35, 01401
2
2014
Theoretical binding efficiencies in bioactive molecular design: a case study on BACE-1 inhibitors
Theoretical binding efficiencies in bioactive molecular design: a case study on BACE- inhibitorsNR Asl, R Miri, A Ebadi, N Edraki, S ShahabipourResearch in Pharmaceutical Sciences 7 (5), 64, 20220
1
2012